Faruk Tas (F Tas, Faruk Taş)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 28

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Postgraduate medicine

Istanbul University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istanbul University

Turkey

Prof Dr. :: Institute of Oncology

Publications

Faruk Tas, Burak Sakar
Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (7) (2022)
Faruk Tas, Kayhan Erturk
Trunk melanomas: no survival differences between lesion sites. Postgraduate medicine 134 (6) (2022)
Faruk Tas, Kayhan Erturk
Ulceration vs. Mitosis in Cutaneous Melanoma: Which Is Superior for Predicting Prognosis Across Clinical Stages? Cancer investigation 40 (10) (2022)
Faruk Tas, Kayhan Erturk
Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma. Journal of cancer research and clinical oncology 147 (9) (2021)
Faruk Tas, Kayhan Erturk
Digit melanomas are associated with poor prognostic factors and unfavorable survivals. Journal of cosmetic dermatology (2021)
Faruk Tas, Kayhan Erturk, Ferhat Ferhatoglu
Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates. Journal of cosmetic dermatology (2021)
Faruk Tas, Kayhan Erturk
Limb melanomas: acral melanomas have worse survival. The Journal of dermatological treatment (2021)
Mustafa Gürbüz, Izzet Dogan, Erman Akkuş, Hande Ermiş, Güngör Utkan, Sezai Vatansever, Faruk Tas
Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data. Dermatologic therapy 34 (6) (2021)
Faruk Tas, Kayhan Erturk, Hilal Oguz Soydinc
Serum folate and vitamin B12 levels in cutaneous melanoma. Journal of cosmetic dermatology 20 (9) (2021)
Faruk Tas, Kayhan Erturk
Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma. International journal of dermatology (2021)
Faruk Tas, Ebru Cinar, Kayhan Erturk
Complementary and alternative medicine (CAM) in Turkish cutaneous melanoma patients: A prospective study from tertiary cancer center. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Faruk Tas, Kayhan Erturk
Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number. Japanese journal of clinical oncology 51 (6) (2021)
Faruk Tas, Kayhan Erturk
BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients. Dermatologic therapy 33 (2) (2020)
Faruk Tas, Kayhan Erturk
Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (1) (2020)
Faruk Tas, Kayhan Erturk
Seasons influence diagnosis and outcome of cutaneous melanoma. Dermatologic therapy 33 (4) (2020)
Faruk Tas, Fatma Ebru Cinar, Kayhan Erturk
Awareness on malignant melanoma and its prevention measures among Turkish cutaneous malignant melanoma patients: A tertiary cancer center experience. Dermatologic therapy 33 (6) (2020)
Faruk Tas, Kayhan Erturk, Hilal Oguz Soydinc
Serum 25-Hydroxyvitamin D Level Is Not Associated with Duration and Activity of Disease in Melanoma Patients. Nutrition and cancer 73 (7) (2020)
Faruk Tas, Kayhan Erturk
Google searching as an indicator of population's interest in melanoma: A comparative study in Google Trends. Dermatologic therapy 33 (6) (2020)
Faruk Tas, Kayhan Erturk
Cutaneous melanoma in vicenarians: Patients in their twenties and older patients show similar clinical behaviors and survival rates. Journal of cosmetic dermatology 19 (10) (2020)
Aysel Bayram, Sule Ozturk Sari, Yasemin Ozluk, Faruk Tas, Nesimi Buyukbabani
Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma. Journal of cutaneous pathology 48 (4) (2020)
Faruk Tas, Can Ozturker
Distichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy. The breast journal 26 (5) (2019)
Faruk Tas, Kayhan Erturk
Spitzoid cutaneous melanoma is associated with favorable clinicopathological factors and outcome. Journal of cosmetic dermatology 18 (6) (2019)
Faruk Tas, Kayhan Erturk
The course of stage III melanoma in accordance with the severity of node involvement. Current medical research and opinion 35 (10) (2019)
Faruk Tas, Kayhan Erturk
Early and late relapses of cutaneous melanoma patients. Postgraduate medicine 131 (3) (2019)
Faruk Tas, Kayhan Erturk
Widespread finger skin metastases of melanoma. Clinical case reports 6 (2) (2018)
Faruk Tas, Kayhan Erturk
Palpebral cutaneous melanomas: a review of 17 cases from a tertiary center. International journal of dermatology 58 (1) (2018)
Faruk Tas, K Erturk
Relapse patterns in patients with local and regional cutaneous melanoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (4) (2018)
Faruk Tas, K Erturk
Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (5) (2017)

Faruk Tas.css-eqlu8i{font-size:small;padding-left:4px;} (F Tas, Faruk Taş)

Publication Activity (10 Years)

Top Topics

Top Venues

Faruk Tas (F Tas, Faruk Taş)